Provided by Tiger Trade Technology Pte. Ltd.

Prothena Corp PLC

9.26
-0.2600-2.73%
Post-market: 9.260.00000.00%16:37 EDT
Volume:430.06K
Turnover:4.01M
Market Cap:498.47M
PE:-2.04
High:9.62
Open:9.42
Low:9.14
Close:9.52
52wk High:13.22
52wk Low:4.32
Shares:53.83M
Float Shares:40.09M
Volume Ratio:0.63
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5346
EPS(LYR):-4.5346
ROE:-63.62%
ROA:-26.40%
PB:1.78
PE(LYR):-2.04

Loading ...

Prothena announced its annual general meeting of shareholders

Reuters
·
11 hours ago

Prothena partners present prasinezumab and BMS-986446 clinical study updates at AD/PD 2026

Reuters
·
Mar 22

Prothena Corporation plc publishes corporate overview presentation on protein dysregulation disease pipeline and USD 308.4 million cash position

Reuters
·
Mar 10

Prothena achieves $50M clinical milestone payment from Novo Nordisk

TIPRANKS
·
Mar 10

Prothena earns USD 50 million milestone payment from Novo Nordisk

Reuters
·
Mar 10

Prothena Announces Achievement of $50 Million Clinical Milestone Payment From Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly Prx004) in Attr Amyloidosis With Cardiomyopathy

THOMSON REUTERS
·
Mar 10

Prothena Corporation Plc - Novo Nordisk Phase 3 Coramitug Trial in Attr-Cm Expected to Complete in 2029

THOMSON REUTERS
·
Mar 10

Prothena (PRTA) Gets a Sell from Bank of America Securities

TIPRANKS
·
Mar 04

Prothena Approves $100 Million Share Buyback Authorization

MT Newswires Live
·
Feb 28

Prothena expects to end year with $255M in cash, equivalents

TIPRANKS
·
Feb 28

Prothena authorizes up to $100.00 million share repurchase plan

Reuters
·
Feb 28

Prothena Announces up to $100 Million Share Repurchase Plan

THOMSON REUTERS
·
Feb 28

Prothena Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Feb 21

RBC Raises Price Target on Prothena to $12 From $11, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
Feb 20

Piper Sandler Remains a Buy on Prothena (PRTA)

TIPRANKS
·
Feb 20

Prothena Q4 net loss narrows

Reuters
·
Feb 20

Prothena Corp Q4 EPS $(0.40) Beats $(0.54) Estimate, Sales $21.000K Miss $1.334M Estimate

Benzinga
·
Feb 20

Prothena Q4 FY2025 revenue hits USD 0.02m and FY2025 net loss totals USD 244.09m

Reuters
·
Feb 20

BRIEF-Prothena Q4 Net Income USD -21.589 Million

Reuters
·
Feb 20

Prothena Q4 Collaboration Revenue USD 21 Thousand

THOMSON REUTERS
·
Feb 20